annual net income:
-$535.60M-$4.16B(-114.80%)Summary
- As of today (September 10, 2025), VRTX annual net profit is -$535.60 million, with the most recent change of -$4.16 billion (-114.80%) on December 31, 2024.
- During the last 3 years, VRTX annual net income has fallen by -$2.88 billion (-122.87%).
- VRTX annual net income is now -114.80% below its all-time high of $3.62 billion, reached on December 31, 2023.
Performance
VRTX Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$1.03B+$386.60M(+59.82%)Summary
- As of today (September 10, 2025), VRTX quarterly net profit is $1.03 billion, with the most recent change of +$386.60 million (+59.82%) on June 30, 2025.
- Over the past year, VRTX quarterly net income has increased by +$4.63 billion (+128.74%).
- VRTX quarterly net income is now -32.26% below its all-time high of $1.52 billion, reached on December 31, 2018.
Performance
VRTX quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$3.64B+$4.63B(+467.84%)Summary
- As of today (September 10, 2025), VRTX TTM net profit is $3.64 billion, with the most recent change of +$4.63 billion (+467.84%) on June 30, 2025.
- Over the past year, VRTX TTM net income has increased by +$4.13 billion (+842.52%).
- VRTX TTM net income is now -9.50% below its all-time high of $4.02 billion, reached on March 31, 2024.
Performance
VRTX TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
VRTX Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -114.8% | +128.7% | +842.5% |
| 3 y3 years | -122.9% | +27.4% | +13.9% |
| 5 y5 years | -145.5% | +23.4% | +74.8% |
VRTX Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -114.8% | at low | -6.1% | +128.7% | -9.5% | +467.8% |
| 5 y | 5-year | -114.8% | at low | -6.1% | +128.7% | -9.5% | +467.8% |
| alltime | all time | -114.8% | +29.0% | -32.3% | +128.7% | -9.5% | +467.8% |
VRTX Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.03B(+59.8%) | $3.64B(-467.8%) |
| Mar 2025 | - | $646.30M(-29.2%) | -$988.90M(+84.6%) |
| Dec 2024 | -$535.60M(-114.8%) | $913.00M(-12.7%) | -$535.60M(+11.6%) |
| Sep 2024 | - | $1.05B(-129.1%) | -$479.80M(-2.1%) |
| Jun 2024 | - | -$3.59B(-426.8%) | -$489.90M(-112.2%) |
| Mar 2024 | - | $1.10B(+13.5%) | $4.02B(+11.0%) |
| Dec 2023 | $3.62B(+9.0%) | $968.80M(-6.4%) | $3.62B(+4.3%) |
| Sep 2023 | - | $1.04B(+13.1%) | $3.47B(+3.1%) |
| Jun 2023 | - | $915.70M(+30.9%) | $3.36B(+3.2%) |
| Mar 2023 | - | $699.80M(-14.5%) | $3.26B(-1.9%) |
| Dec 2022 | $3.32B(+41.8%) | $818.90M(-12.0%) | $3.32B(+1.5%) |
| Sep 2022 | - | $930.50M(+14.8%) | $3.27B(+2.5%) |
| Jun 2022 | - | $810.50M(+6.4%) | $3.19B(+30.3%) |
| Mar 2022 | - | $762.10M(-1.0%) | $2.45B(+4.7%) |
| Dec 2021 | $2.34B(-13.6%) | $770.10M(-9.6%) | $2.34B(+7.6%) |
| Sep 2021 | - | $851.93M(+1173.0%) | $2.18B(+9.3%) |
| Jun 2021 | - | $66.92M(-89.8%) | $1.99B(-27.9%) |
| Mar 2021 | - | $653.14M(+8.1%) | $2.76B(+1.9%) |
| Dec 2020 | $2.71B(+130.4%) | $604.19M(-9.5%) | $2.71B(+0.8%) |
| Sep 2020 | - | $667.43M(-20.3%) | $2.69B(+29.3%) |
| Jun 2020 | - | $837.27M(+38.9%) | $2.08B(+37.7%) |
| Mar 2020 | - | $602.75M(+3.3%) | $1.51B(+28.4%) |
| Dec 2019 | $1.18B(-43.6%) | $583.23M(+914.0%) | $1.18B(-44.4%) |
| Sep 2019 | - | $57.52M(-78.5%) | $2.12B(-3.2%) |
| Jun 2019 | - | $267.43M(-0.4%) | $2.19B(+2.9%) |
| Mar 2019 | - | $268.63M(-82.4%) | $2.13B(+2.0%) |
| Dec 2018 | $2.09B(+2184.4%) | $1.52B(+1087.1%) | $2.09B(+214.3%) |
| Sep 2018 | - | $128.44M(-37.7%) | $663.92M(+171.9%) |
| Jun 2018 | - | $206.19M(-9.3%) | $244.22M(+253.0%) |
| Mar 2018 | - | $227.20M(+122.5%) | $69.18M(-24.1%) |
| Dec 2017 | $91.34M(-208.7%) | $102.09M(-135.1%) | $91.12M(+443.0%) |
| Sep 2017 | - | -$291.27M(-1035.2%) | $16.78M(-93.8%) |
| Jun 2017 | - | $31.15M(-87.5%) | $268.51M(+33.4%) |
| Mar 2017 | - | $249.14M(+797.5%) | $201.21M(-339.5%) |
| Dec 2016 | -$84.03M(-85.7%) | $27.76M(-170.2%) | -$84.03M(-55.4%) |
| Sep 2016 | - | -$39.54M(+9.4%) | -$188.24M(-22.4%) |
| Jun 2016 | - | -$36.15M(+0.1%) | -$242.52M(-43.3%) |
| Mar 2016 | - | -$36.10M(-52.8%) | -$427.36M(-27.6%) |
| Dec 2015 | -$588.18M(-20.7%) | -$76.45M(-18.5%) | -$589.96M(-15.0%) |
| Sep 2015 | - | -$93.82M(-57.5%) | -$694.15M(-9.9%) |
| Jun 2015 | - | -$220.99M(+11.2%) | -$770.33M(+8.7%) |
| Mar 2015 | - | -$198.70M(+10.0%) | -$708.72M(-4.5%) |
| Dec 2014 | -$741.83M(+7.9%) | -$180.64M(+6.3%) | -$742.47M(-0.5%) |
| Sep 2014 | - | -$170.00M(+6.7%) | -$746.38M(+5.9%) |
| Jun 2014 | - | -$159.38M(-31.4%) | -$705.05M(+16.1%) |
| Mar 2014 | - | -$232.46M(+26.0%) | -$607.38M(-11.7%) |
| Dec 2013 | -$687.55M(+1244.6%) | -$184.55M(+43.4%) | -$687.55M(+18.3%) |
| Sep 2013 | - | -$128.66M(+108.5%) | -$581.08M(+21.3%) |
| Jun 2013 | - | -$61.71M(-80.3%) | -$478.88M(+6.0%) |
| Mar 2013 | - | -$312.63M(+300.4%) | -$451.64M(+767.9%) |
| Dec 2012 | -$51.13M(-225.1%) | -$78.08M(+195.0%) | -$52.04M(-124.3%) |
| Sep 2012 | - | -$26.47M(-23.2%) | $213.88M(-54.2%) |
| Jun 2012 | - | -$34.47M(-139.6%) | $466.67M(+54.6%) |
| Mar 2012 | - | $86.97M(-53.7%) | $301.82M(+678.8%) |
| Dec 2011 | $40.89M(-105.4%) | $187.85M(-17.0%) | $38.75M(-111.8%) |
| Sep 2011 | - | $226.32M(-213.5%) | -$329.49M(-56.9%) |
| Jun 2011 | - | -$199.32M(+13.2%) | -$764.76M(-0.1%) |
| Mar 2011 | - | -$176.10M(-2.4%) | -$765.45M(+1.4%) |
| Dec 2010 | -$754.63M(+17.5%) | -$180.39M(-13.7%) | -$754.63M(+3.0%) |
| Sep 2010 | - | -$208.96M(+4.5%) | -$732.88M(+8.8%) |
| Jun 2010 | - | -$200.01M(+21.0%) | -$673.49M(+4.5%) |
| Mar 2010 | - | -$165.27M(+4.2%) | -$644.78M(+0.4%) |
| Dec 2009 | -$642.18M(+39.6%) | -$158.64M(+6.1%) | -$642.18M(+2.6%) |
| Sep 2009 | - | -$149.56M(-12.7%) | -$625.87M(+3.2%) |
| Jun 2009 | - | -$171.30M(+5.3%) | -$606.35M(+15.2%) |
| Mar 2009 | - | -$162.67M(+14.3%) | -$526.37M(+14.5%) |
| Dec 2008 | -$459.85M(+17.5%) | -$142.33M(+9.4%) | -$459.85M(+14.0%) |
| Sep 2008 | - | -$130.04M(+42.4%) | -$403.27M(+6.1%) |
| Jun 2008 | - | -$91.32M(-5.0%) | -$380.26M(-6.5%) |
| Mar 2008 | - | -$96.15M(+12.1%) | -$406.70M(+3.9%) |
| Dec 2007 | -$391.28M | -$85.75M(-19.9%) | -$391.28M(+17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$107.03M(-9.1%) | -$332.87M(+19.9%) |
| Jun 2007 | - | -$117.77M(+45.9%) | -$277.64M(+16.9%) |
| Mar 2007 | - | -$80.73M(+195.2%) | -$237.53M(+14.2%) |
| Dec 2006 | -$207.94M(+2.2%) | -$27.34M(-47.2%) | -$207.94M(-4.9%) |
| Sep 2006 | - | -$51.80M(-33.3%) | -$218.72M(-11.3%) |
| Jun 2006 | - | -$77.66M(+51.9%) | -$246.50M(+17.5%) |
| Mar 2006 | - | -$51.13M(+34.1%) | -$209.83M(+3.2%) |
| Dec 2005 | -$203.42M(+22.4%) | -$38.13M(-52.1%) | -$203.42M(-2.2%) |
| Sep 2005 | - | -$79.58M(+94.1%) | -$208.06M(+24.4%) |
| Jun 2005 | - | -$40.99M(-8.3%) | -$167.25M(-1.9%) |
| Mar 2005 | - | -$44.72M(+4.6%) | -$170.53M(+2.6%) |
| Dec 2004 | -$166.25M(-37.6%) | -$42.77M(+10.3%) | -$166.25M(+1.5%) |
| Sep 2004 | - | -$38.77M(-12.4%) | -$163.83M(-22.5%) |
| Jun 2004 | - | -$44.27M(+9.5%) | -$211.48M(-17.8%) |
| Mar 2004 | - | -$40.44M(+0.2%) | -$257.14M(+31.1%) |
| Dec 2003 | -$266.41M(+145.3%) | -$40.35M(-53.3%) | -$196.09M(+4.4%) |
| Sep 2003 | - | -$86.42M(-3.9%) | -$187.82M(+39.3%) |
| Jun 2003 | - | -$89.93M(-536.3%) | -$134.85M(+104.5%) |
| Mar 2003 | - | $20.61M(-164.2%) | -$65.94M(-39.3%) |
| Dec 2002 | -$108.62M(+58.8%) | -$32.08M(-4.1%) | -$108.62M(+20.5%) |
| Sep 2002 | - | -$33.45M(+59.2%) | -$90.14M(+4.9%) |
| Jun 2002 | - | -$21.02M(-4.7%) | -$85.92M(+11.6%) |
| Mar 2002 | - | -$22.07M(+62.3%) | -$77.00M(+20.7%) |
| Dec 2001 | -$68.42M(+87.5%) | -$13.60M(-53.5%) | -$63.81M(+22.0%) |
| Sep 2001 | - | -$29.23M(+141.4%) | -$52.32M(+9.1%) |
| Jun 2001 | - | -$12.11M(+36.5%) | -$47.95M(+106.4%) |
| Mar 2001 | - | -$8.87M(+319.8%) | -$23.23M(-23.9%) |
| Dec 2000 | -$36.50M(-10.9%) | -$2.11M(-91.5%) | -$30.52M(+14.3%) |
| Sep 2000 | - | -$24.86M(-297.1%) | -$26.69M(+65.6%) |
| Jun 2000 | - | $12.61M(-178.1%) | -$16.12M(-59.3%) |
| Mar 2000 | - | -$16.16M(-1042.2%) | -$39.57M(-3.4%) |
| Dec 1999 | -$40.97M(+23.8%) | $1.72M(-112.0%) | -$40.97M(-25.9%) |
| Sep 1999 | - | -$14.29M(+31.8%) | -$55.28M(+27.8%) |
| Jun 1999 | - | -$10.84M(-38.2%) | -$43.27M(+2.5%) |
| Mar 1999 | - | -$17.55M(+39.4%) | -$42.23M(+27.6%) |
| Dec 1998 | -$33.09M(+66.8%) | -$12.60M(+454.2%) | -$33.09M(+21.2%) |
| Sep 1998 | - | -$2.27M(-76.8%) | -$27.29M(-11.7%) |
| Jun 1998 | - | -$9.80M(+16.5%) | -$30.92M(+37.3%) |
| Mar 1998 | - | -$8.41M(+23.7%) | -$22.51M(+13.1%) |
| Dec 1997 | -$19.83M(-50.4%) | -$6.80M(+15.3%) | -$19.90M(+17.1%) |
| Sep 1997 | - | -$5.90M(+321.4%) | -$17.00M(-2.3%) |
| Jun 1997 | - | -$1.40M(-75.9%) | -$17.40M(-54.6%) |
| Mar 1997 | - | -$5.80M(+48.7%) | -$38.30M(-4.3%) |
| Dec 1996 | -$40.01M(+85.8%) | -$3.90M(-38.1%) | -$40.00M(+8.4%) |
| Sep 1996 | - | -$6.30M(-71.7%) | -$36.90M(-1.6%) |
| Jun 1996 | - | -$22.30M(+197.3%) | -$37.50M(+55.0%) |
| Mar 1996 | - | -$7.50M(+837.5%) | -$24.20M(+13.1%) |
| Dec 1995 | -$21.53M(+22.4%) | -$800.00K(-88.4%) | -$21.40M(-16.1%) |
| Sep 1995 | - | -$6.90M(-23.3%) | -$25.50M(+13.3%) |
| Jun 1995 | - | -$9.00M(+91.5%) | -$22.50M(+18.4%) |
| Mar 1995 | - | -$4.70M(-4.1%) | -$19.00M(+8.6%) |
| Dec 1994 | -$17.59M(-963.8%) | -$4.90M(+25.6%) | -$17.50M(+348.7%) |
| Sep 1994 | - | -$3.90M(-29.1%) | -$3.90M(+44.4%) |
| Jun 1994 | - | -$5.50M(+71.9%) | -$2.70M(-235.0%) |
| Mar 1994 | - | -$3.20M(-136.8%) | $2.00M(+5.3%) |
| Dec 1993 | $2.04M(-124.0%) | $8.70M(-422.2%) | $1.90M(-120.0%) |
| Sep 1993 | - | -$2.70M(+237.5%) | -$9.50M(+5.6%) |
| Jun 1993 | - | -$800.00K(-75.8%) | -$9.00M(-10.9%) |
| Mar 1993 | - | -$3.30M(+22.2%) | -$10.10M(+20.2%) |
| Dec 1992 | -$8.49M(+65.0%) | -$2.70M(+22.7%) | -$8.40M(+20.0%) |
| Sep 1992 | - | -$2.20M(+15.8%) | -$7.00M(+16.7%) |
| Jun 1992 | - | -$1.90M(+18.8%) | -$6.00M(+9.1%) |
| Mar 1992 | - | -$1.60M(+23.1%) | -$5.50M(+7.8%) |
| Dec 1991 | -$5.14M(+19.6%) | -$1.30M(+8.3%) | -$5.10M(+4.1%) |
| Sep 1991 | - | -$1.20M(-14.3%) | -$4.90M(+2.1%) |
| Jun 1991 | - | -$1.40M(+16.7%) | -$4.80M(+6.7%) |
| Mar 1991 | - | -$1.20M(+9.1%) | -$4.50M(+4.7%) |
| Dec 1990 | -$4.30M | -$1.10M(0.0%) | -$4.30M(+34.4%) |
| Sep 1990 | - | -$1.10M(0.0%) | -$3.20M(+52.4%) |
| Jun 1990 | - | -$1.10M(+10.0%) | -$2.10M(+110.0%) |
| Mar 1990 | - | -$1.00M | -$1.00M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual net profit?
- What is the all time high annual net income for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual net income year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly net profit?
- What is the all time high quarterly net income for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly net income year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM net profit?
- What is the all time high TTM net income for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM net income year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual net profit?
The current annual net income of VRTX is -$535.60M
What is the all time high annual net income for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual net profit is $3.62B
What is Vertex Pharmaceuticals Incorporated annual net income year-on-year change?
Over the past year, VRTX annual net profit has changed by -$4.16B (-114.80%)
What is Vertex Pharmaceuticals Incorporated quarterly net profit?
The current quarterly net income of VRTX is $1.03B
What is the all time high quarterly net income for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly net profit is $1.52B
What is Vertex Pharmaceuticals Incorporated quarterly net income year-on-year change?
Over the past year, VRTX quarterly net profit has changed by +$4.63B (+128.74%)
What is Vertex Pharmaceuticals Incorporated TTM net profit?
The current TTM net income of VRTX is $3.64B
What is the all time high TTM net income for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM net profit is $4.02B
What is Vertex Pharmaceuticals Incorporated TTM net income year-on-year change?
Over the past year, VRTX TTM net profit has changed by +$4.13B (+842.52%)